Leukemia is a neoplastic diseases of the bone marrow in which unrestrained proliferation of white blood cells occurs, usually accompanied by anemia, impaired blood clotting, and enlargement of the lymph nodes, liver, and spleen.
New alternative to biopsy detects subtle changes in cancer cells, Stanford study shows. – A drop of blood or a chunk of tissue smaller than the period at the end of this sentence may one day be all that is necessary to diagnose cancers and assess their response to treatment, say researchers at the Stanford University School of Medicine.
World first treatment for leukemia being developed in Australia – Two Australian research groups are undertaking pioneering studies into the causes of leukaemia, potentially leading to patients receiving new drug treatments as early as next year.
Health Minister invites diaspora to join in developing healthcare – Indian Health Minister Dr. Anbumani Ramadoss has called for public-private partnership in health sector to meet the gap between supply and demand.
Grape seed extract kills laboratory leukemia cells, proving value of natural compounds. – An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, according to researchers from the University of Kentucky. They found that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract.
Millions of people infected with HIV may hope for healing promises, as a patient who has had undetectable HIV viral loads for almost two years after bone marrow transplant. – An HIV-positive person, who underwent a bone marrow transplant to treat leukemia, has had undetectable HIV viral loads for almost two years. HIV-positive man was ill from leukemia and had underwent treatment by the team led by Prof. Eckhard Thiel, director of the Medical Clinic with a focus on hematology and oncology.
Hannah Jones – a British Girl – won a legal case that allowed her to refuse a life-saving heart transplant surgery. – A British girl 13 years old, suffering from leukemia, Hannah Jones decided to refuse to have a heart transplant for her heart condition – a hole in her heart.
Scientists find new genes linked to lung cancer. Discovery opens door to individualized treatment strategies. – Working as part of a multi-institutional collaboration, scientists at Washington University School of Medicine in St. Louis have assembled the most complete catalog to date of the genetic changes underlying the most common form of lung cancer.
A promising new chemotherapy target for a deadly form of leukemia has been discovered by researchers at the Stanford University Medical Center, US. – Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel “double agent” role for a molecular signal that regulates cell growth.
FDA approved Amgen’s Nplate (romiplostim), the first product that directly stimulates the bone marrow to produce needed platelets in patients with a rare blood disorder ITP that can lead to serious bleeding. – The U.S. Food and Drug Administration approved Nplate (romiplostim), the first product that directly stimulates the bone marrow to produce needed platelets in patients with a rare blood disorder that can lead to serious bleeding.
Female who receive a kidney from a male donor are more likely to reject the kidney or graft, suggested by the Swiss researchers. – There are more chances of kidney rejection in a woman who gets a kidney from a male donor, revealed by Swiss researchers in a research paper published in the current issue of the medical journal The Lancet from UK.
Interim analysis supports continuation of Cell Genesys’ VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer – Cell Genesys, Inc. (Nasdaq: CEGE) announced that the Independent Data Monitoring Committee (IDMC) for VITAL-1, the first of two ongoing Phase 3 clinical trials of GVAX immunotherapy for prostate cancer, has completed a pre-planned interim analysis and has recommended that the study continue, as GVAX cancer immunotherapy improves prostate cancer patients survival.
A new study of four-year-old twin girls has identified a stem cell that is the root cause of childhood cancer – Acute lymphoblastic leukaemia (ALL). – A breakthrough study of identical twins has for the first time confirmed the existence of cancer stem cells that cause the most common form of childhood cancer, acute lymphoblastic leukaemia (ALL) ? backing evidence that this childhood cancer starts in the womb. The research should lead to less aggressive treatment for childhood ALL and provides the hope of new, more effective drugs.
